Imiquimod (VAdv-Ly0029)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0029 |
|
Imiquimod, a TLR7 agonist vaccine adjuvant.
Datasheet
Specifications
Type
PRRs Agonist
Formula
C14H16N4▪HCl
Molecular Weight
276.8
Specificity
TLR7 agonist
Product Form
White solid
Endotoxin
Lower than 5 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
Imiquimod, derived from guanosine and belonging to the imidazoquinoline class of compounds, serves as an agonist for TLR7. This compound modifies immune responses by potently activating dendritic cells and B cells, leading to the production of cytokines that promote Th1 cell immunity and antibody generation. It exhibits significant antiviral and antitumor properties through these mechanisms.
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
